These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17711537)

  • 1. Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets.
    Tothfalusi L; Speidl S; Endrenyi L
    Br J Clin Pharmacol; 2008 Jan; 65(1):110-22. PubMed ID: 17711537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Existing and new criteria for bioequivalence evaluation of new controlled release (CR) products of carbamazepine.
    Bialer M; Arcavi L; Sussan S; Volosov A; Yacobi A; Moros D; Levitt B; Laor A
    Epilepsy Res; 1998 Nov; 32(3):371-8. PubMed ID: 9839777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults.
    Chien S; Bialer M; Solanki B; Verhaeghe T; Doose DR; Novak G; Yao C
    Epilepsia; 2006 Nov; 47(11):1830-40. PubMed ID: 17116022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
    Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approvable generic carbamazepine formulations may not be bioequivalent in target patient populations.
    Tothfalusi L; Endrenyi L
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):525-8. PubMed ID: 23611573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
    Miller AD; Krauss GL; Hamzeh FM
    Acta Neurol Scand; 2004 Jun; 109(6):374-7. PubMed ID: 15147458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration.
    Wangemann M; Retzow A; Evers G; Mazur D; Schug B; Blume H
    Arzneimittelforschung; 1998 Dec; 48(12):1131-7. PubMed ID: 9893926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria to assess in vivo performance and bioequivalence of generic controlled-release formulations of carbamazepine.
    Bialer M; Yacobi A; Moros D; Levitt B; Houle JM; Munsaka MS
    Epilepsia; 1998 May; 39(5):513-9. PubMed ID: 9596204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of care, outcomes, and direct health plan costs of antiepileptic therapy: a pharmacoeconomic analysis of the available carbamazepine formulations.
    Garnett WR; Gilbert TD; O'Connor P
    Clin Ther; 2005 Jul; 27(7):1092-103. PubMed ID: 16154489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the in vitro and in vivo pharmacokinetic profiles of once-daily modified-release methylphenidate formulations in Canada: examination of current bioequivalence criteria.
    Shram MJ; Quinn AM; Chen N; Faulknor J; Luong D; Sellers EM; Endrenyi L
    Clin Ther; 2012 May; 34(5):1170-81. PubMed ID: 22512898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
    Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS
    Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.
    Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A
    Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of drug levels & pharmacokinetics of carbamazepine with seizure control.
    Vasudev A; Tripathi KD; Puri V
    Indian J Med Res; 2000 Dec; 112():218-23. PubMed ID: 11247200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment.
    Cawello W; Bökens H; Nickel B; Andreas JO; Halabi A
    Epilepsia; 2013 Jan; 54(1):81-8. PubMed ID: 23148731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits.
    García AL; Medina RL; Pérez MR; Jung CH
    Biopharm Drug Dispos; 2003 Jul; 24(5):205-9. PubMed ID: 12784320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.